Safety of allergen-specific immunotherapy. Relation between dosage regimen, allergen extract, disease and systemic side-effects during induction treatment

Clinical and Experimental Allergy

Volumn 30, Issue 10, 2000, Pages 1423-1429

  Mellerup, M T ^a   Hahn, G W ^a   Poulsen, L K ^a   Malling, H J ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Allergen extracts; Allergen specific immunotherapy; Allergic diseases; Compliance; Induction regimens; Systemic side effects

Indexed keywords

ALUTARD; AQUAGEN SQ; HYMENOPTERA VENOM;

ADOLESCENT; ADULT; AGED; ALLERGIC RHINITIS; ANAPHYLAXIS; ARTICLE; ASTHMA; DESENSITIZATION; DOSE TIME EFFECT RELATION; DRUG COST; DRUG SAFETY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSTIMULATION; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ALLERGENS; FEMALE; HUMANS; HYPERSENSITIVITY; IMMUNOTHERAPY; MALE; RETROSPECTIVE STUDIES; SEX FACTORS;

EID: 0033774038     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.2000.00910.x     Document Type: Article

References (9)

1. Immunotherapy as an effective tool in allergy treatment
2. EAACI Immunotherapy position papers
3. WHO Position Paper Allergen Immunotherapy: Therapeutic Vaccines for Allergic Diseases
4. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. III. Systemic reactions during the rash protocol in patients suffering from asthma
5. A prospective safety-monitoring study of immunotherapy with biologically standardized extracts
6. Side effects during immunotherapy with purified grass pollen extracts
7. Late and immediate systemic allergic reactions to inhalant allergen immunotherapy
8. Systemic reactions to immunotherapy: Comparisons between two large allergy practices
9. Nonfatal systemic reactions to subcutaneous immunotherapy: A 10-year experience